Abstract
The inability to engage in the usual activities of daily living is one of the most distressing experiences of people afflicted with chronic obstructive pulmonary disease (COPD). Exercise intolerance progresses relentlessly as the disease advances, contributing to reduced quality of life. It has become clear that in COPD, exercise intolerance ultimately reflects complex integrated abnormalities of the ventilatory, cardiovascular, peripheral muscle and neurosensory systems that vary in degree from patient to patient. Ventilatory limitation and perceived respiratory difficulty are often the dominant contributors to exercise curtailment in more advanced disease, but not necessarily the only ones. Recently, there has been great interest in the role of cardiovascular and peripheral muscle dysfunction (and their interaction) in exercise limitation in COPD. In this review, we examine in some detail the pathophysiological derangements that are evident during exercise in COPD with the hope of identifying specific mechanisms that are amenable to therapeutic manipulation.
Keywords: COPD, exercise, ventilatory mechanics, dyspnea, dynamic hyperinflation, muscle dysfunction, energy metabolism
Current Respiratory Medicine Reviews
Title: Exercise Limitation in Chronic Obstructive Pulmonary Disease
Volume: 4 Issue: 4
Author(s): Pierantonio Laveneziana, Karin Wadell, Katherine Webb and Denis E. O'Donnell
Affiliation:
Keywords: COPD, exercise, ventilatory mechanics, dyspnea, dynamic hyperinflation, muscle dysfunction, energy metabolism
Abstract: The inability to engage in the usual activities of daily living is one of the most distressing experiences of people afflicted with chronic obstructive pulmonary disease (COPD). Exercise intolerance progresses relentlessly as the disease advances, contributing to reduced quality of life. It has become clear that in COPD, exercise intolerance ultimately reflects complex integrated abnormalities of the ventilatory, cardiovascular, peripheral muscle and neurosensory systems that vary in degree from patient to patient. Ventilatory limitation and perceived respiratory difficulty are often the dominant contributors to exercise curtailment in more advanced disease, but not necessarily the only ones. Recently, there has been great interest in the role of cardiovascular and peripheral muscle dysfunction (and their interaction) in exercise limitation in COPD. In this review, we examine in some detail the pathophysiological derangements that are evident during exercise in COPD with the hope of identifying specific mechanisms that are amenable to therapeutic manipulation.
Export Options
About this article
Cite this article as:
Laveneziana Pierantonio, Wadell Karin, Webb Katherine and O'Donnell E. Denis, Exercise Limitation in Chronic Obstructive Pulmonary Disease, Current Respiratory Medicine Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339808786263752
DOI https://dx.doi.org/10.2174/157339808786263752 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Diagnosis and Management of Endocrine Hypertension in Children and Adolescents
Current Pharmaceutical Design Cardiac Dysfunction in Rats with Dietary-Induced Insulin Resistance Associated with Pharmacologically-induced Dyslipidemia
Current Pharmaceutical Design Psychological Stress and the Development of Heart Disease
Current Psychiatry Reviews Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry Targeting the Inflammatory Response in Healing Myocardial Infarcts
Current Medicinal Chemistry Heparins with Reduced Anti-Coagulant Activity Reduce Myocardial Reperfusion Injury
Recent Patents on Cardiovascular Drug Discovery Surgical Ventricular Restoration to Reverse Left Ventricular Remodeling
Current Cardiology Reviews New Inotropic Pharmacologic Strategies Targeting the Failing Myocardiumin the Newborn and Infant
Mini-Reviews in Medicinal Chemistry Pharmacological Applications of Antioxidants: Lights and Shadows
Current Drug Targets Modulators of the Vascular Endothelin Receptor in Blood Pressure Regulation and Hypertension
Current Molecular Pharmacology Emerging Concepts on Inhibitors of Indoleamine 2,3-Dioxygenase in Rheumatic Diseases
Current Medicinal Chemistry Role of Subclinical Iatrogenic Hyperthyroidism in the Setting of Heart Disease and Arrhythmic Burden
Endocrine, Metabolic & Immune Disorders - Drug Targets Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design Uncontrolled Hypertension and Oncology: Clinical Tips
Current Vascular Pharmacology Clinical Trials Using Vasodilators in Pulmonary Arterial Hypertension:Where Do We Go from Here?
Reviews on Recent Clinical Trials Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology Nano-Systems for Advanced Therapeutics and Diagnosis of Atherosclerosis
Current Pharmaceutical Design Cerebral Vascular Aging: Extending the Concept of Pulse Wave Encephalopathy Through Capillaries to the Cerebral Veins
Current Aging Science Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects
Current Drug Metabolism Hypertension, Cognitive Impairment and Dementia: An Epidemiological Perspective
Current Hypertension Reviews